This Article Full Text Full Text (PDF) Online Data Supplement Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Anthonisen, N. R. Articles by Murray, R. P. Search for Related Content PubMed PubMed Citation Articles by Anthonisen, N. R. Articles by Murray, R. P.

Smoking and Lung Function of Lung Health Study Participants after 11 Years

University of Manitoba, Winnipeg, Manitoba, Canada; and University of Minnesota, Minneapolis, Minnesota

Correspondence and requests for reprints should be addressed to John E. Connett, Ph.D., Biostatistics/CCBR, 2221 University Avenue SE, Suite 200, Minneapolis, MN 55414-3080. E-mail: john-c{at}ccbr.umn.edu

Eleven years after Lung Health Study (LHS) entry, we performed spirometry in 77.4% of surviving participants who enrolled in a long-term follow-up study. Those not enrolling tended to be younger male heavy smokers who continued to smoke during the LHS. Their initial LHS lung function, after adjustment for these factors, did not differ from that of enrollees. Smoking habits by original LHS treatment groups (smoking intervention vs. usual care) tended to converge, but 93% of participants who were abstinent throughout the LHS were still abstinent at 11 years. Differences in lung function between treatment groups persisted; smoking intervention participants had less decline in FEV₁ than usual care participants. Men who quit at the beginning of the LHS had an FEV₁ rate of decline of 30.2 ml/year, whereas women who quit declined at 21.5 ml/year. Men continuing to smoke throughout the 11 years declined by 66.1 ml/year, and women continuing to smoke declined by 54.2 ml/year. When decline in FEV₁ was expressed as a percentage of predicted normal value, no significant sex-based difference was apparent among continuing smokers. At 11 years, 38% of continuing smokers had an FEV₁ less than 60% of the predicted normal value compared with 10% of sustained quitters.

Key Words: clinical trial • COPD • lung function • smoking intervention

This article has been cited by other articles:

				A. B. Newman, M. C. Sachs, A. M. Arnold, L. P. Fried, R. Kronmal, M. Cushman, B. M. Psaty, T. B. Harris, J. A. Robbins, G. L. Burke, et al. Total and Cause-Specific Mortality in the Cardiovascular Health Study J Gerontol A Biol Sci Med Sci, December 1, 2009; 64A(12): 1251 - 1261. [Abstract] [Full Text] [PDF]

				M. Shan, H.-F. Cheng, L.-z. Song, L. Roberts, L. Green, J. Hacken-Bitar, J. Huh, F. Bakaeen, H. O. Coxson, C. Storness-Bliss, et al. Lung Myeloid Dendritic Cells Coordinately Induce TH1 and TH17 Responses in Human Emphysema Science Translational Medicine, October 28, 2009; 1(4): 4ra10 - 4ra10. [Abstract] [Full Text] [PDF]

				P G Gibson and J L Simpson The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax, August 1, 2009; 64(8): 728 - 735. [Abstract] [Full Text] [PDF]

				B. D. Broekhuizen, A. P. Sachs, R. Oostvogels, A. W Hoes, T. J. Verheij, and K. G. Moons The diagnostic value of history and physical examination for COPD in suspected or known cases: a systematic review Fam. Pract., August 1, 2009; 26(4): 260 - 268. [Abstract] [Full Text] [PDF]

				R. Kohansal, P. Martinez-Camblor, A. Agusti, A. S. Buist, D. M. Mannino, and J. B. Soriano The Natural History of Chronic Airflow Obstruction Revisited: An Analysis of the Framingham Offspring Cohort Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 3 - 10. [Abstract] [Full Text] [PDF]

				C. E Bolton, J. R Cockcroft, R. Sabit, M. Munnery, C. M McEniery, I. B Wilkinson, S. Ebrahim, J. E Gallacher, D. J Shale, and Y. Ben-Shlomo Lung function in mid-life compared with later life is a stronger predictor of arterial stiffness in men: The Caerphilly Prospective Study Int. J. Epidemiol., June 1, 2009; 38(3): 867 - 876. [Abstract] [Full Text] [PDF]

				R. Kohansal, J. B. Soriano, and A. Agusti Investigating the Natural History of Lung Function: Facts, Pitfalls, and Opportunities Chest, May 1, 2009; 135(5): 1330 - 1341. [Abstract] [Full Text] [PDF]

				D E O'Donnell, P Laveneziana, J Ora, K A Webb, Y-M Lam, and D Ofir Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD Thorax, March 1, 2009; 64(3): 216 - 223. [Abstract] [Full Text] [PDF]

				P L Enright GOLD stage 1 is crying wolf Thorax, February 1, 2009; 64(2): 182 - 183. [Full Text] [PDF]

				G. S. Skloot, C. B. Schechter, R. Herbert, J. M. Moline, S. M. Levin, L. E. Crowley, B. J. Luft, I. G. Udasin, and P. L. Enright Longitudinal Assessment of Spirometry in the World Trade Center Medical Monitoring Program Chest, February 1, 2009; 135(2): 492 - 498. [Abstract] [Full Text] [PDF]

				S. I. Rennard and J. Vestbo Natural Histories of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, December 15, 2008; 5(9): 878 - 883. [Abstract] [Full Text] [PDF]

				R. P. Young, R. J. Hopkins, B. A. Hay, M. J. Epton, P. N. Black, and G. D. Gamble Lung cancer gene associated with COPD: triple whammy or possible confounding effect? Eur. Respir. J., November 1, 2008; 32(5): 1158 - 1164. [Abstract] [Full Text] [PDF]

				N. S. Godtfredsen, T. H. Lam, T. T. Hansel, M. E. Leon, N. Gray, C. Dresler, D. M. Burns, E. Prescott, and J. Vestbo COPD-related morbidity and mortality after smoking cessation: status of the evidence Eur. Respir. J., October 1, 2008; 32(4): 844 - 853. [Abstract] [Full Text] [PDF]

				B. R. Celli, N. E. Thomas, J. A. Anderson, G. T. Ferguson, C. R. Jenkins, P. W. Jones, J. Vestbo, K. Knobil, J. C. Yates, and P. M. A. Calverley Effect of Pharmacotherapy on Rate of Decline of Lung Function in Chronic Obstructive Pulmonary Disease: Results from the TORCH Study Am. J. Respir. Crit. Care Med., August 15, 2008; 178(4): 332 - 338. [Abstract] [Full Text] [PDF]

				A. M. Kuzma, Y. Meli, C. Meldrum, P. Jellen, M. Butler-Lebair, D. Koczen-Doyle, P. Rising, K. Stavrolakes, and F. Brogan Multidisciplinary Care of the Patient with Chronic Obstructive Pulmonary Disease Proceedings of the ATS, May 1, 2008; 5(4): 567 - 571. [Abstract] [Full Text] [PDF]

				M Bednarek, J Maciejewski, M Wozniak, P Kuca, and J Zielinski Prevalence, severity and underdiagnosis of COPD in the primary care setting Thorax, May 1, 2008; 63(5): 402 - 407. [Abstract] [Full Text] [PDF]

				D. Ofir, P. Laveneziana, K. A. Webb, Y.-M. Lam, and D. E. O'Donnell Mechanisms of Dyspnea during Cycle Exercise in Symptomatic Patients with GOLD Stage I Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 15, 2008; 177(6): 622 - 629. [Abstract] [Full Text] [PDF]

				S D Aaron, D Fergusson, G B Marks, S Suissa, K L Vandemheen, S Doucette, F Maltais, J F Bourbeau, R S Goldstein, M Balter, et al. Counting, analysing and reporting exacerbations of COPD in randomised controlled trials Thorax, February 1, 2008; 63(2): 122 - 128. [Abstract] [Full Text] [PDF]

				A. Guenegou, J. Boczkowski, M. Aubier, F. Neukirch, and B. Leynaert Interaction between a Heme Oxygenase-1 Gene Promoter Polymorphism and Serum -Carotene Levels on 8-Year Lung Function Decline in a General Population: The European Community Respiratory Health Survey (France) Am. J. Epidemiol., January 15, 2008; 167(2): 139 - 144. [Abstract] [Full Text] [PDF]

				M. K. Han, V. V. McLaughlin, G. J. Criner, and F. J. Martinez Pulmonary Diseases and the Heart Circulation, December 18, 2007; 116(25): 2992 - 3005. [Abstract] [Full Text] [PDF]

				G. Viegi, F. Pistelli, D. L. Sherrill, S. Maio, S. Baldacci, and L. Carrozzi Definition, epidemiology and natural history of COPD Eur. Respir. J., November 1, 2007; 30(5): 993 - 1013. [Abstract] [Full Text] [PDF]

				R. P. Young, R. Hopkins, and T. E. Eaton Forced expiratory volume in one second: not just a lung function test but a marker of premature death from all causes Eur. Respir. J., October 1, 2007; 30(4): 616 - 622. [Abstract] [Full Text] [PDF]

				S. I. Rennard Inflammation in COPD: a link to systemic comorbidities Eur. Respir. Rev., September 1, 2007; 16(105): 91 - 97. [Abstract] [Full Text] [PDF]

				N. Roche Where current pharmacological therapies fall short in COPD: symptom control is not enough Eur. Respir. Rev., September 1, 2007; 16(105): 98 - 104. [Abstract] [Full Text] [PDF]

				F. J. Martinez, J. L. Curtis, F. Sciurba, J. Mumford, N. D. Giardino, G. Weinmann, E. Kazerooni, S. Murray, G. J. Criner, D. D. Sin, et al. Sex Differences in Severe Pulmonary Emphysema Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 243 - 252. [Abstract] [Full Text] [PDF]

				P. White, M. Bednarek, D. Gorecka, and J. Zielinski Spirometric screening for COPD: wishful thinking, not evidence Thorax, August 1, 2007; 62(8): 742 - 743. [Full Text] [PDF]

				P. Tonnesen, L. Carrozzi, K. O. Fagerstrom, C. Gratziou, C. Jimenez-Ruiz, S. Nardini, G. Viegi, C. Lazzaro, I. A. Campell, E. Dagli, et al. Smoking cessation in patients with respiratory diseases: a high priority, integral component of therapy Eur. Respir. J., February 1, 2007; 29(2): 390 - 417. [Abstract] [Full Text] [PDF]

				L Shahab, M J Jarvis, J Britton, and R West Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample Thorax, December 1, 2006; 61(12): 1043 - 1047. [Abstract] [Full Text] [PDF]

				N R Anthonisen "Susceptible" smokers? Thorax, November 1, 2006; 61(11): 924 - 925. [Full Text] [PDF]

				A Lokke, P Lange, H Scharling, P Fabricius, and J Vestbo Developing COPD: a 25 year follow up study of the general population. Thorax, November 1, 2006; 61(11): 935 - 939. [Abstract] [Full Text] [PDF]

				S. Verbanck, D. Schuermans, M. Paiva, M. Meysman, and W. Vincken Small Airway Function Improvement after Smoking Cessation in Smokers without Airway Obstruction Am. J. Respir. Crit. Care Med., October 15, 2006; 174(8): 853 - 857. [Abstract] [Full Text] [PDF]

				S F P Man, J E Connett, N R Anthonisen, R A Wise, D P Tashkin, and D D Sin C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease Thorax, October 1, 2006; 61(10): 849 - 853. [Abstract] [Full Text] [PDF]

				M Bednarek, D Gorecka, J Wielgomas, M Czajkowska-Malinowska, J Regula, G Mieszko-Filipczyk, M Jasionowicz, R Bijata-Bronisz, M Lempicka-Jastrzebska, M Czajkowski, et al. Smokers with airway obstruction are more likely to quit smoking Thorax, October 1, 2006; 61(10): 869 - 873. [Abstract] [Full Text] [PDF]

				D. D Sin and S. P. Man Commentary: Fuelling the fire--systemic inflammation and development of lung disease in the general community Int. J. Epidemiol., August 1, 2006; 35(4): 1008 - 1010. [Full Text] [PDF]

				S. I. Rennard Chronic Obstructive Pulmonary Disease: Linking Outcomes and Pathobiology of Disease Modification Proceedings of the ATS, May 1, 2006; 3(3): 276 - 280. [Abstract] [Full Text] [PDF]

				G. Gartlehner, R. A. Hansen, S. S. Carson, and K. N. Lohr Efficacy and Safety of Inhaled Corticosteroids in Patients With COPD: A Systematic Review and Meta-Analysis of Health Outcomes Ann. Fam. Med, May 1, 2006; 4(3): 253 - 262. [Abstract] [Full Text] [PDF]

				S. Sethi, J. Maloney, L. Grove, C. Wrona, and C. S. Berenson Airway Inflammation and Bronchial Bacterial Colonization in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., May 1, 2006; 173(9): 991 - 998. [Abstract] [Full Text] [PDF]

				S. Chinn, D. Jarvis, C. Svanes, and P. Burney Sources of variation in forced expiratory volume in one second and forced vital capacity. Eur. Respir. J., April 1, 2006; 27(4): 767 - 773. [Abstract] [Full Text] [PDF]

				J. Zielinski, M. Bednarek, D. Gorecka, G. Viegi, S. S. Hurd, Y. Fukuchi, C. K. W. Lai, P. X. Ran, F. W. S. Ko, S. M. Liu, et al. Increasing COPD awareness. Eur. Respir. J., April 1, 2006; 27(4): 833 - 852. [Full Text] [PDF]

				S. I. Rennard, N. Schachter, M. Strek, K. Rickard, and O. Amit Cilomilast for COPD: Results of a 6-Month, Placebo-Controlled Study of a Potent, Selective Inhibitor of Phosphodiesterase 4 Chest, January 1, 2006; 129(1): 56 - 66. [Abstract] [Full Text] [PDF]

				W. T. L. Hu and J. F. Malouf 75-Year-Old Man With Progressive Shortness of Breath on Exertion Mayo Clin. Proc., December 1, 2005; 80(12): 1651 - 1654. [PDF]

				B. W. M. Willemse, N. H. T. ten Hacken, B. Rutgers, I. G. A. T. Lesman-Leegte, D. S. Postma, and W. Timens Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers Eur. Respir. J., November 1, 2005; 26(5): 835 - 845. [Abstract] [Full Text] [PDF]

				S. I. Rennard and J. A. Stoner Challenges and Opportunities for Combination Therapy in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 391 - 393. [Abstract] [Full Text] [PDF]

				R. M. Geijer, A. P. Sachs, A. W Hoes, P. L Salome, J.-W. J Lammers, and T. J. Verheij Prevalence of undetected persistent airflow obstruction in male smokers 40-65 years old Fam. Pract., October 1, 2005; 22(5): 485 - 489. [Abstract] [Full Text] [PDF]

				P. K. Myint, R. N. Luben, P. G. Surtees, N. W. J. Wainwright, A. A. Welch, S. A. Bingham, N. J. Wareham, N. E. Day, and K-T. Khaw Respiratory function and self-reported functional health: EPIC-Norfolk population study Eur. Respir. J., September 1, 2005; 26(3): 494 - 502. [Abstract] [Full Text] [PDF]

				S. A. Schroeder What to Do With a Patient Who Smokes JAMA, July 27, 2005; 294(4): 482 - 487. [Abstract] [Full Text] [PDF]

				N. R. Anthonisen, P. G. Lindgren, D. P. Tashkin, R. E. Kanner, P. D. Scanlon, J. E. Connett, and for the Lung Health Study Research Group Bronchodilator response in the lung health study over 11 yrs Eur. Respir. J., July 1, 2005; 26(1): 45 - 51. [Abstract] [Full Text] [PDF]

				T. Higenbottam Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease: A Case for Treatment Proceedings of the ATS, April 1, 2005; 2(1): 12 - 19. [Abstract] [Full Text] [PDF]

				R. Buhl and S. G. Farmer Future Directions in the Pharmacologic Therapy of Chronic Obstructive Pulmonary Disease Proceedings of the ATS, April 1, 2005; 2(1): 83 - 93. [Abstract] [Full Text] [PDF]

				M Decramer, R Gosselink, P Bartsch, C-G Lofdahl, W Vincken, R Dekhuijzen, J Vestbo, R Pauwels, R Naeije, and T Troosters Effect of treatments on the progression of COPD: report of a workshop held in Leuven, 11-12 March 2004 Thorax, April 1, 2005; 60(4): 343 - 349. [Abstract] [Full Text] [PDF]

				N. R. Anthonisen, M. A. Skeans, R. A. Wise, J. Manfreda, R. E. Kanner, J. E. Connett, and for the Lung Health Study Research Group* The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial Ann Intern Med, February 15, 2005; 142(4): 233 - 239. [Abstract] [Full Text] [PDF]

				N.C. Thomson, R. Chaudhuri, and E. Livingston Asthma and cigarette smoking Eur. Respir. J., November 1, 2004; 24(5): 822 - 833. [Abstract] [Full Text] [PDF]

				H. K. Eltzschig, T. Eckle, T. W. Felbinger, M. H. Lavietes, S. Kumar, B. Sinha, M. Joy, E. R. Sutherland, and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., September 30, 2004; 351(14): 1461 - 1463. [Full Text] [PDF]

				The TORCH Study Group The TORCH (TOwards a Revolution in COPD Health) survival study protocol Eur. Respir. J., August 1, 2004; 24(2): 206 - 210. [Abstract] [Full Text] [PDF]

				F. C. Sciurba Physiologic Similarities and Differences Between COPD and Asthma Chest, August 1, 2004; 126(2_suppl_1): 117S - 124S. [Abstract] [Full Text] [PDF]

				E. R. Sutherland and R. M. Cherniack Management of Chronic Obstructive Pulmonary Disease N. Engl. J. Med., June 24, 2004; 350(26): 2689 - 2697. [Full Text] [PDF]

				M. Greenstone Review: inhaled corticosteroids slow the progression of airflow limitation in COPD Evid. Based Med., May 1, 2004; 9(3): 75 - 75. [Full Text] [PDF]

				L Portengen, A Hollander, G Doekes, G de Meer, and D Heederik Authors' reply Occup. Environ. Med., May 1, 2004; 61(5): 475 - 475. [Full Text] [PDF]

				N. R. Anthonisen Lessons from the Lung Health Study Proceedings of the ATS, April 1, 2004; 1(2): 143 - 145. [Full Text] [PDF]

				B.W.M. Willemse, D.S. Postma, W. Timens, and N.H.T. ten Hacken The impact of smoking cessation on respiratory symptoms, lung function, airway hyperresponsiveness and inflammation Eur. Respir. J., March 1, 2004; 23(3): 464 - 476. [Abstract] [Full Text] [PDF]

				R. Edwards The problem of tobacco smoking BMJ, January 24, 2004; 328(7433): 217 - 219. [Full Text] [PDF]

				E R Sutherland, H Allmers, N T Ayas, A J Venn, and R J Martin Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis Thorax, November 1, 2003; 58(11): 937 - 941. [Abstract] [Full Text] [PDF]

				I. Cerveri, S. Accordini, A. Corsico, M.C. Zoia, L. Carrozzi, L. Cazzoletti, M. Beccaria, A. Marinoni, G. Viegi, and R. de Marco Chronic cough and phlegm in young adults Eur. Respir. J., September 1, 2003; 22(3): 413 - 417. [Abstract] [Full Text] [PDF]

				D. Price and M. Duerden Chronic obstructive pulmonary disease BMJ, May 15, 2003; 326(7398): 1046 - 1047. [Full Text] [PDF]

				T. L. Croxton, G. G. Weinmann, R. M. Senior, R. A. Wise, J. D. Crapo, and A. S. Buist Clinical Research in Chronic Obstructive Pulmonary Disease: Needs and Opportunities Am. J. Respir. Crit. Care Med., April 15, 2003; 167(8): 1142 - 1149. [Abstract] [Full Text] [PDF]

				M. J. Tobin Chronic Obstructive Pulmonary Disease, Pollution, Pulmonary Vascular Disease, Transplantation, Pleural Disease, and Lung Cancer in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 356 - 370. [Full Text] [PDF]